« Back
Home /
Recombinant Kidney Injury Molecule 1 (Kim1)

Recombinant Kidney Injury Molecule 1 (Kim1)

Item no.	RPA785Ca01-10ug
Manufacturer	Cloud-Clone
Amount	10 ug
Quantity options	100 ug 10 ug 1 mg 200 ug 500 ug 50 ug
Category	Peptides & Proteins Recombinant Proteins
Type	Proteins
Applications	WB, SDS-PAGE, other
Specific against	Dog (Canine, Canis lupus familiaris)
Host	E.coli
Conjugate/Tag	HIS
Purity	> 90%
Sequence	Gln23ca.Glu125
NCBI	NM_001205114.1
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	HAVCR1; TIM1; TIMD1; HAVCR; Hepatitis A Virus Cellular Receptor 1; T Cell Immunoglobulin And Mucin Domain-Containing Protein 1; T-cell immunoglobulin mucin receptor 1
Similar products	HAVCR1, TIM1, TIMD1, HAVCR, Hepatitis A Virus Cellular Receptor 1, T Cell Immunoglobulin And Mucin Domain-Containing Protein 1, T-cell immunoglobulin mucin receptor 1
Available
Sequence	Gln23ca.Glu125
Predicted Molecular Mass(KD)	12.6kDa
Accurate Molecular Mass(KD)	14kDa
Purity	> 90%
Uniprot Link	http://www.ncbi.nlm.nih.gov/nuccore/NM_001205114.1
Subcellular location	Membrane
Isoelectric Point	6, 8
Item Name	Kidney Injury Molecule 1
Alternative Names	HAVCR1, TIM1, TIMD1, HAVCR, Hepatitis A Virus Cellular Receptor 1, T Cell Immunoglobulin And Mucin Domain-Containing Protein 1, T-cell immunoglobulin mucin receptor 1
Buffer	PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Traits	Freeze-dried powder
Tag	N-terminal His Tag
Research Area	Tumor immunity; Infection immunity; Kidney biomarker;
Expression System	Prokaryotic expression
Appilcaiton info	Positive Control, Immunogen, SDS-PAGE, WB.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.